Binding members for human cytomegalovirus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9346874
APP PUB NO 20130089559A1
SERIAL NO

13530891

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to binding members, especially antibody molecules, which may neutralize the biological effects of human cytomegalovirus (hCMV). The binding members may be useful for the treatment and prophylaxis of hCMV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AGENUS INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Grawunder, Ulf Basel, CH 31 129
Mach, Michael Erlangen, DE 4 23
Martin-Parras, Luis Jena, DE 1 12
Potzsch, Sonja Hersbruck, DE 1 0
Spindler, Nadja Erlangen, DE 4 19
Sticht, Heinrich Furth, DE 2 12
Wiegers, Anna-Katharina Nuremberg, DE 1 12
Winkler, Thomas Erlangen, DE 85 798

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00